{"paper_id":"8b387062-ed72-4d4e-a35b-6d5158cea328","body_text":"Abstract\nEndometriosis involving the presence and growth of glands and stroma outside the uterine cavity is a common, inflammatory, benign gynecologic disease. Nevertheless, no single theory can exactly account for the pathogenesis of endometriosis. Telocytes, a kind of novel mesenchymal cells, have been suggested to be crucial in promoting angiogenesis and increasing the activity of endometrial interstitial cells and inflammatory cells. Given above roles, telocytes may be considered as the possible pathogenesis of endometriosis. We reviewed the current literature on telocytes. The following aspects were considered: (A) the telocytes’ typical characteristics, function, and morphological changes in endometriosis; (B) the potential role of telocytes in endometriosis by impacting the inflammation, invasion, and angiogenesis; (C) telocytes as the potential treatment options for endometriosis.\nSimilar content being viewed by others\nReferences\nVigano P, Somigliana E, Panina P, Rabellotti E, Vercellini P, Candiani M (2012) Principles of phenomics in endometriosis. Hum Reprod Update 18(3):248–259. https://doi.org/10.1093/humupd/dms001\nBlum S, Fasching PA, Hildebrandt T, Lermann J, Heindl F, Born T et al (2022) Comprehensive characterization of endometriosis patients and disease patterns in a large clinical cohort. Arch Gynecol Obstet 305(4):977–984. https://doi.org/10.1007/s00404-021-06200-w\nZondervan KT, Becker CM, Missmer SA (2020) Endometriosis. N Engl J Med 382(13):1244–1256. https://doi.org/10.1056/NEJMra1810764\nRogers PA, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA, Zondervan KT (2009) Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 16(4):335–346. https://doi.org/10.1177/1933719108330568\nJiang QY, Wu RJ (2012) Growth mechanisms of endometriotic cells in implanted places: a review. Gynecol Endocrinol 28(7):562–567. https://doi.org/10.3109/09513590.2011.650662\nRogers PA, Donoghue JF, Walter LM, Girling JE (2009) Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci 16(2):147–151. https://doi.org/10.1177/1933719108325509\nMarquardt RM, Kim TH, Shin JH, Jeong JW (2019) Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis. Int J Mol Sci. https://doi.org/10.3390/ijms20153822\nWang Y, Nicholes K, Shih IM (2020) The origin and pathogenesis of endometriosis. Annu Rev Pathol 15:71–95. https://doi.org/10.1146/annurev-pathmechdis-012419-032654\nXu T, Lu SS, Zhang HQ (2016) Transmission electron microscope evidence of telocytes in canine dura mater. J Cell Mol Med 20(1):188–192. https://doi.org/10.1111/jcmm.12726\nZhang HQ, Lu SS, Xu T, Feng YL, Li H, Ge JB (2015) Morphological evidence of telocytes in mice aorta. Chin Med J 128(3):348–352. https://doi.org/10.4103/0366-6999.150102 (Engl)\nLi YY, Lu SS, Xu T, Zhang HQ, Li H (2015) Comparative analysis of telomerase activity in CD117(+) CD34(+) cardiac telocytes with bone mesenchymal stem cells, cardiac fibroblasts and cardiomyocytes. Chin Med J 128(14):1942–1947. https://doi.org/10.4103/0366-6999.160560 (Engl)\nGherghiceanu M, Manole CG, Popescu LM (2010) Telocytes in endocardium: electron microscope evidence. J Cell Mol Med 14(9):2330–2334. https://doi.org/10.1111/j.1582-4934.2010.01133.x\nSuciu L, Popescu LM, Gherghiceanu M, Regalia T, Nicolescu MI, Hinescu ME, Faussone-Pellegrini MS (2010) Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs 192(5):325–339. https://doi.org/10.1159/000319467\nZheng Y, Li H, Manole CG, Sun A, Ge J, Wang X (2011) Telocytes in trachea and lungs. J Cell Mol Med 15(10):2262–2268. https://doi.org/10.1111/j.1582-4934.2011.01404.x\nPopescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, Popescu BO (2011) Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med 15(6):1379–1392. https://doi.org/10.1111/j.1582-4934.2011.01330.x\nCretoiu SM, Cretoiu D, Marin A, Radu BM, Popescu LM (2013) Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction 145(4):357–370. https://doi.org/10.1530/REP-12-0369\nXiao J, Wang F, Liu Z, Yang C (2013) Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med 17(12):1537–1542. https://doi.org/10.1111/jcmm.12195\nAleksandrovych V, Walocha JA, Gil K (2016) Telocytes in female reproductive system (human and animal). J Cell Mol Med 20(6):994–1000. https://doi.org/10.1111/jcmm.12843\nVarga I, Urban L, Kajanova M, Polak S (2016) Functional histology and possible clinical significance of recently discovered telocytes inside the female reproductive system. Arch Gynecol Obstet 294(2):417–422. https://doi.org/10.1007/s00404-016-4106-x\nXu T, Zhu ZL, Wu CQ, KE JY, Zhang HQ (2021) Identification and morphological features of telocytes in endometriosis. Chinese J Pathophysiol 37(5):921–927\nShafik A, El-Sibai O, Shafik I, Shafik AA (2005) Immunohistochemical identification of the pacemaker cajal cells in the normal human vagina. Arch Gynecol Obstet 272(1):13–16. https://doi.org/10.1007/s00404-005-0725-3\nHatta K, Huang ML, Weisel RD, Li RK (2012) Culture of rat endometrial telocytes. J Cell Mol Med 16(7):1392–1396. https://doi.org/10.1111/j.1582-4934.2012.01583.x\nUrban L, Miko M, Kajanova M, Bozikova S, Mrazova H, Varga I (2016) Telocytes (interstitial Cajal-like cells) in human fallopian tubes. Bratisl Lek Listy 117(5):263–267. https://doi.org/10.4149/bll_2016_051\nCiontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, Braga RI, Malincenco M, Zagrean L, Hinescu ME, Popescu LM (2005) C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med 9(2):407–420. https://doi.org/10.1111/j.1582-4934.2005.tb00366.x\nGherghiceanu M, Popescu LM (2005) Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. transmission electron microscope (TEM) identification. J Cell Mol Med 9(4):893–910. https://doi.org/10.1111/j.1582-4934.2005.tb00387.x\nPieri L, Vannucchi MG, Faussone-Pellegrini MS (2008) Histochemical and ultrastructural characteristics of an interstitial cell type different from ICC and resident in the muscle coat of human gut. J Cell Mol Med 12(5B):1944–1955. https://doi.org/10.1111/j.1582-4934.2008.00461.x\nPopescu LM, Faussone-Pellegrini MS (2010) TELOCYTES—a case of serendipity: the winding way from interstitial cells of cajal (ICC), via interstitial cajal-like cells (ICLC) to TELOCYTES. J Cell Mol Med 14(4):729–740. https://doi.org/10.1111/j.1582-4934.2010.01059.x\nManole CG, Cismasiu V, Gherghiceanu M, Popescu LM (2011) Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med 15(11):2284–2296. https://doi.org/10.1111/j.1582-4934.2011.01449.x\nPopescu LM, Gherghiceanu M, Suciu LC, Manole CG, Hinescu ME (2011) Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res 345(3):391–403. https://doi.org/10.1007/s00441-011-1229-z\nCretoiu D, Ciontea SM, Popescu LM, Ceafalan L, Ardeleanu C (2006) Interstitial Cajal-like cells (ICLC) as steroid hormone sensors in human myometrium: immunocytochemical approach. J Cell Mol Med 10(3):789–795. https://doi.org/10.1111/j.1582-4934.2006.tb00438.x\nPopescu LM, Gherghiceanu M, Manole CG, Faussone-Pellegrini MS (2009) Cardiac renewing: interstitial cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med 13(5):866–886. https://doi.org/10.1111/j.1582-4934.2009.00758.x\nYang J, Chi C, Liu Z, Yang G, Shen ZJ, Yang XJ (2015) Ultrastructure damage of oviduct telocytes in rat model of acute salpingitis. J Cell Mol Med 19(7):1720–1728. https://doi.org/10.1111/jcmm.12548\nYang XJ, Yang J, Liu Z, Yang G, Shen ZJ (2015) Telocytes damage in endometriosis-affected rat oviduct and potential impact on fertility. J Cell Mol Med 19(2):452–462. https://doi.org/10.1111/jcmm.12427\nAleksandrovych V, Pasternak A, Gil K (2019) Telocytes in the architecture of uterine fibroids. Folia Med Cracov 59(4):33–44. https://doi.org/10.24425/fmc.2019.131378\nKamergorodsky G, Ribeiro PA, Galvao MA, Abrao MS, Donadio N, Lemos NL, Aoki T (2009) Histologic classification of specimens from women affected by superficial endometriosis, deeply infiltrating endometriosis, and ovarian endometriomas. Fertil Steril 92(6):2074–2077. https://doi.org/10.1016/j.fertnstert.2009.05.086\nSzukiewicz D, Stangret A, Ruiz-Ruiz C, Olivares EG, Soriţău O, Suşman S, Szewczyk G (2021) Estrogen- and progesterone (P4)-mediated epigenetic modifications of endometrial stromal cells (EnSCs) and/or mesenchymal stem/stromal cells (MSCs) in the etiopathogenesis of endometriosis. Stem Cell Rev Rep 17(4):1174–1193. https://doi.org/10.1007/s12015-020-10115-5\nTang XL, Zhang FL, Jiang XJ, Yang XJ (2019) Telocytes enhanced the proliferation, adhesion and motility of endometrial stromal cells as mediated by the ERK pathway in vitro. Am J Transl Res 11(2):572–585\nKlemmt PA, Carver JG, Koninckx P, McVeigh EJ, Mardon HJ (2007) Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Hum Reprod 22(12):3139–3147. https://doi.org/10.1093/humrep/dem262\nBanu SK, Lee J, Speights VJ, Starzinski-Powitz A, Arosh JA (2008) Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 149(3):1180–1189. https://doi.org/10.1210/en.2007-1168\nDelbandi AA, Mahmoudi M, Shervin A, Akbari E, Jeddi-Tehrani M, Sankian M, Kazemnejad S, Zarnani AH (2013) Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior. Fertil Steril 100(3):761–769. https://doi.org/10.1016/j.fertnstert.2013.04.041\nAleksandrovych V, Kurnik-Lucka M, Bereza T, Białas M, Pasternak A, Cretoiu D, Walocha JA, Gil K (2019) The autonomic innervation and uterine telocyte interplay in leiomyoma formation. Cell Transpl 28(5):619–629. https://doi.org/10.1177/0963689719833303\nKondo A, Kaestner KH (2019) Emerging diverse roles of telocytes. Development. https://doi.org/10.1242/dev.175018\nKlein M, Lapides L, Fecmanova D, Varga I (2020) From TELOCYTES to TELOCYTOPATHIES do recently described interstitial cells play a role in female idiopathic infertility? Medicina. https://doi.org/10.3390/medicina56120688\nJanas P, Kucybala I, Radon-Pokracka M, Huras H (2018) Telocytes in the female reproductive system an overview of up to date knowledge. Adv Clin Exp Med. https://doi.org/10.17219/acem/68845\nGherghiceanu M, Popescu LM (2012) Cardiac telocytes - their junctions and functional implications. Cell Tissue Res 348(2):265–279. https://doi.org/10.1007/s00441-012-1333-8\nWang L, Song D, Wei C, Chen C, Yang YW, Deng XY, Gu JY (2020) Telocytes inhibited inflammatory factor expression and enhanced cell migration in LPS-induced skin wound healing models in vitro and in vivo. J Transl Med 18(1):60. https://doi.org/10.1186/s12967-020-02217-y\nKlemmt P, Starzinski-Powitz A (2018) Molecular and cellular pathogenesis of endometriosis. Curr Womens Health Rev 14(2):106–116. https://doi.org/10.2174/1573404813666170306163448\nShigesi N, Kvaskoff M, Kirtley S, Feng Q, Fang H, Knight JC, Missmer SA, Rahmioglu N, Zondervan KT, Becker CM (2019) The association between endometriosis and autoimmune diseases:a systematic review and meta-analysis. Hum Reprod Update 25(4):486–503. https://doi.org/10.1093/humupd/dmz014\nSymons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C (2018) The immunopathophysiology of endometriosis. Trends Mol Med 24(9):748–762. https://doi.org/10.1016/j.molmed.2018.07.004\nRolla E (2019) Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000Res. https://doi.org/10.12688/f1000research.14817.1\nKhoufache K, Michaud N, Harir N, Bondza PK, Akoum A (2012) Anomalies in the inflammatory response in endometriosis and possible consequences a review. Minerva Endocrino 37(1):75–92\nWeiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS (2009) Inflammation in reproductive disorders. Reprod Sci 16(2):216–229. https://doi.org/10.1177/1933719108330087\nMalhotra N, Karmakar D, Tripathi V, Luthra K, Kumar S (2012) Correlation of angiogenic cytokines-leptin and IL-8 in stage, type and presentation of endometriosis. Gynecol Endocrinol 28(3):224–227. https://doi.org/10.3109/09513590.2011.593664\nAhn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C (2015) Pathophysiology and immune dysfunction in endometriosis. Biomed Res Int. https://doi.org/10.1155/2015/795976\nBeste MT, Pfaffle-Doyle N, Prentice EA, Morris SN, Lauffenburger DA, Isaacson KB, Griffith LG (2014) Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci Transl Med 6(222):216r–222r. https://doi.org/10.1126/scitranslmed.3007988\nKoch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Mr EV, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089):1798–1801. https://doi.org/10.1126/science.1281554\nMcLaren J, Prentice A, Charnock-Jones DS, Millican SA, Müller KH, Sharkey AM, Smith SK (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98(2):482–489. https://doi.org/10.1172/JCI118815\nBacci M, Capobianco A, Monno A, Cottone L, Puppo FD, Camisa B et al (2009) Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 175(2):547–556. https://doi.org/10.2353/ajpath.2009.081011\nCretoiu SM, Popescu LM (2014) Telocytes revisited. Biomol Concepts 5(5):353–369. https://doi.org/10.1515/bmc-2014-0029\nBosco C, Diaz E, Gutierrez R, Gonzalez J, Parra-Cordero M, Rodrigo R, Barja P (2015) A putative role for telocytes in placental barrier impairment during preeclampsia. Med Hypotheses 84(1):72–77. https://doi.org/10.1016/j.mehy.2014.11.019\nCretoiu SM, Cretoiu D, Popescu LM (2012) Human myometrium—the ultrastructural 3D network of telocytes. J Cell Mol Med 16(11):2844–2849. https://doi.org/10.1111/j.1582-4934.2012.01651.x\nChi C, Jiang XJ, Su L, Shen ZJ, Yang XJ (2015) In vitro morphology, viability and cytokine secretion of uterine telocyte-activated mouse peritoneal macrophages. J Cell Mol Med 19(12):2741–2750. https://doi.org/10.1111/jcmm.12711\nJiang XJ, Cretoiu D, Shen ZJ, Yang XJ (2018) An in vitro investigation of telocytes-educated macrophages: morphology, heterocellular junctions, apoptosis and invasion analysis. J Transl Med 16(1):85. https://doi.org/10.1186/s12967-018-1457-z\nCheng J, Yang HL, Gu CJ, Liu YK, Shao J, Zhu R, He YY, Zhu XY, Li MQ (2019) Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1alpha/ROS/VEGF. Int J Mol Med 43(2):945–955. https://doi.org/10.3892/ijmm.2018.4021\nGacche RN, Meshram RJ (2013) Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 113(2):333–354. https://doi.org/10.1016/j.pbiomolbio.2013.10.001\nPark JH, Yoon J, Park B (2016) Pomolic acid suppresses HIF1alpha/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades. Phytomedicine 23(14):1716–1726. https://doi.org/10.1016/j.phymed.2016.10.010\nKrikun G (2012) Endometriosis, angiogenesis and tissue factor. Scientifica 2012:306830. https://doi.org/10.6064/2012/306830 (Cairo)\nGilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A (2007) Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 22(8):2120–2127. https://doi.org/10.1093/humrep/dem149\nTaylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD, Sidell N (2009) Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 16(2):140–146. https://doi.org/10.1177/1933719108324893\nBourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M (2006) The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-a and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 132(3):501–509. https://doi.org/10.1530/rep.1.01110\nZheng Y, Chen X, Qian M, Zhang MM, Zhang D, Bai CX, Wang Q, Wang XD (2014) Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro. Mol Cell Ther 2:3. https://doi.org/10.1186/2052-8426-2-3\nKucybala I, Janas P, Ciuk S, Cholopiak W, Klimek-Piotrowska W, Holda MK (2017) A comprehensive guide to telocytes and their great potential in cardiovascular system. Bratisl Lek Listy 118(5):302–309. https://doi.org/10.4149/BLL_2017_059\nRisau W (1997) Mechanisms of angiogenesis. Nature 386(6626):671–674. https://doi.org/10.1038/386671a0\nAsahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3):221–228. https://doi.org/10.1161/01.res.85.3.221\nMitrofanova L, Hazratov A, Galkovsky B, Gorshkov A, Bobkov D, Gulyaev D, Shlyakhto E (2020) Morphological and immunophenotypic characterization of perivascular interstitial cells in human glioma telocytes pericytes and mixed immunophenotypes. Oncotarget 11(4):322–346. https://doi.org/10.18632/oncotarget.27340\nZheng Y, Wang X (2016) Roles of telocytes in the development of angiogenesis. Adv Exp Med Biol 913:253–261. https://doi.org/10.1007/978-981-10-1061-3_17\nLi H, Lu SS, Liu HN, Ge JB, Zhang HQ (2014) Scanning electron microscope evidence of telocytes in vasculature. J Cell Mol Med 18(7):1486–1489. https://doi.org/10.1111/jcmm.12333\nLi H, Zhang HQ, Yang L, Lu SS, Zhang HQ (2014) Telocytes in mice bone marrow: electron microscope evidence. J Cell Mol Med 18(6):975–978. https://doi.org/10.1111/jcmm.12337\nReynolds LP, Borowicz PP, Caton JS, Vonnahme KA, Luther JS, Buchanan DS, Hafez SA, Grazul-Bilska AT, Redmer DA (2010) Uteroplacental vascular development and placental function:an update. Int J Dev Biol 54(2–3):355–366. https://doi.org/10.1387/ijdb.082799lr\nCismasiu VB, Radu E, Popescu LM (2011) miR-193 expression differentiates telocytes from other stromal cells. J Cell Mol Med 15(5):1071–1074. https://doi.org/10.1111/j.1582-4934.2011.01325.x\nSoliman SA (2021) Telocytes are major constituents of the angiogenic apparatus. Sci Rep 11(1):5775. https://doi.org/10.1038/s41598-021-85166-w\nFreitag N, Pour SJ, Fehm TN, Toth B, Markert UR, Weber M, Togawa R, Kruessel JS, Baston-Buest DM, Bielfeld AP (2020) Are uterine natural killer and plasma cells in infertility patients associated with endometriosis, repeated implantation failure, or recurrent pregnancy loss? Arch Gynecol Obstet 302(6):1487–1494. https://doi.org/10.1007/s00404-020-05679-z\nShi C, Xu HG, Zhang T, Gao YC (2022) Endometriosis decreases female sexual function and increases pain severity: a meta-analysis. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-022-06478-4\nKlein M, Csobonyeiova M, Danisovic L, Lapides L, Varga I (2022) Telocytes in the female reproductive system: up-to-date knowledge ,challenges and possible clinical applications. Life. https://doi.org/10.3390/life12020267 (Basel)\nTanbo T, Fedorcsak P (2017) Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand 96(6):659–667. https://doi.org/10.1111/aogs.13082\nMazzoni TS, Viadanna RR, Quagio-Grassiotto I (2019) Presence, localization and morphology of TELOCYTES in developmental gonads of fishes. J Morphol 280(5):654–665. https://doi.org/10.1002/jmor.20972\nLi C, Zhao HL, Li YJ, Zhang YY, Liu HY, Feng FZ, Yan H (2021) The expression and significance of leukemia inhibitory factor, interleukin-6 and vascular endothelial growth factor in Chinese patients with endometriosis. Arch Gynecol Obstet 304(1):163–170. https://doi.org/10.1007/s00404-021-05980-5\nYuan W, Wu YH, Chai XS, Wu XQ (2022) The colonized microbiota composition in the peritoneal fluid in women with endometriosis. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-021-06338-7\nSmolarz B, Szyllo K, Romanowicz H (2021) Endometriosis: epidemiology classification pathogenesis treatment and genetics (review of literature). Int J Mol Sci. https://doi.org/10.3390/ijms221910554\nHuang YL, Zhang FL, Tang XL, Yang XJ (2021) Telocytes enhances m1 differentiation and phagocytosis while inhibits mitochondria-mediated apoptosis via activation of NF-kappaB in macrophages. Cell Transpl 30:83906678. https://doi.org/10.1177/09636897211002762\nLi LP, Lin M, Li L, Wang R, Zhang C, Qi GS, Xu M, Rong RM, Zhu TY (2014) Renal telocytes contribute to the repair of ischemically injured renal tubules. J Cell Mol Med 18(6):1144–1156. https://doi.org/10.1111/jcmm.12274\nCampeanu RA, Radu BM, Cretoiu SM, Banciu DD, Banciu A, Cretoiu D, Popescu LM (2014) Near-infrared low-level laser stimulation of telocytes from human myometrium. Lasers Med Sci 29(6):1867–1874. https://doi.org/10.1007/s10103-014-1589-1\nKlein M, Csobonyeiova M, Ziaran S, DaniSovic L, Varga I (2021) Cardiac telocytes 16 years on-what have we learned so far, and how close are we to routine application of the knowledge in cardiovascular regenerative medicine? Int J Mol Sci. https://doi.org/10.3390/ijms222010942\nFunding\nThe authors have not disclosed any funding.\nAuthor information\nAuthors and Affiliations\nContributions\nTX: literature searching and manuscript writing. HQZ: manuscript editing. ZLZ: manuscript reviewing, editing, and approving.\nCorresponding author\nEthics declarations\nConflict of interest\nThe authors declare no conflict of interest.\nEthical approval\nThe study was approved by the Ethic Committee of Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. It was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.\nInformed consent\nInformed consent was obtained from all individual participants included in the study.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nAbout this article\nCite this article\nXu, T., Zhang, H. & Zhu, Z. Telocytes and endometriosis. Arch Gynecol Obstet 307, 39–49 (2023). https://doi.org/10.1007/s00404-022-06634-w\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-022-06634-w","source_license":"CC0","license_restricted":false}